How AI could replace animal testing
AI-summarised brief · reviewed before publication
Scientists across Europe are integrating artificial intelligence, human cell cultures and organ‑on‑a‑chip technologies to predict the toxicity of chemicals, aiming to replace the roughly 150,000 rats and mice used annually under the EU’s REACH regulation. The effort is coordinated by the €60 million ASPIS research cluster, which funds three initiatives, including Professor John Colbourne’s programme at the University of Birmingham and Professor Mathieu Vinken’s ONTOX project in Belgium. These projects target chronic toxicity testing, which is costly—up to €15 million per substance and several years—and often yields limited relevance to human health. By 2026 the teams hope to demonstrate AI‑driven, in‑vitro methods that meet safety requirements while adhering to the EU’s three‑Rs principle of replacement, reduction and refinement of animal use.
💡 Why It Matters
- · Successful AI‑based testing could slash billions in compliance costs and accelerate market entry for new chemicals, reshaping the regulatory landscape for safety assessment.